Literature DB >> 20425068

Cholesterol in beta-cell dysfunction: the emerging connection between HDL cholesterol and type 2 diabetes.

Liam R Brunham1, Janine K Kruit, Michael R Hayden, C Bruce Verchere.   

Abstract

Beta-cell dysfunction is a critical step in the pathogenesis of type 2 diabetes. The mechanisms responsible for beta-cell death and dysfunction remain incompletely understood, but include glucolipotoxicity, the deleterious metabolic milieu created by high plasma concentrations of glucose and lipid species. Recently, an important role has emerged for cholesterol in this process. In this article, we review recent advances in our understanding of the role of ABCA1 and cholesterol metabolism in beta-cell function, with particular attention to insights gained from human studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425068     DOI: 10.1007/s11892-009-0090-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  43 in total

Review 1.  Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.

Authors:  S E Kahn
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

Review 2.  Lipotoxic diseases.

Authors:  Roger H Unger
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

3.  Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.

Authors:  Laurent Yvan-Charvet; Mollie Ranalletta; Nan Wang; Seongah Han; Naoki Terasaka; Rong Li; Carrie Welch; Alan R Tall
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

4.  Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure.

Authors:  Takayoshi Tsutamoto; Masayuki Yamaji; Chiho Kawahara; Keizo Nishiyama; Masanori Fujii; Takashi Yamamoto; Minoru Horie
Journal:  Eur J Heart Fail       Date:  2009-11-04       Impact factor: 15.534

5.  Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells.

Authors:  Sabine Rütti; Jan A Ehses; Rahel A Sibler; Richard Prazak; Lucia Rohrer; Spiros Georgopoulos; Daniel T Meier; Nadja Niclauss; Thierry Berney; Marc Y Donath; Arnold von Eckardstein
Journal:  Endocrinology       Date:  2009-07-23       Impact factor: 4.736

6.  Association of the ATP-binding cassette transporter A1 R230C variant with early-onset type 2 diabetes in a Mexican population.

Authors:  M Teresa Villarreal-Molina; M Teresa Flores-Dorantes; Olimpia Arellano-Campos; Marisela Villalobos-Comparan; Maricela Rodríguez-Cruz; Angel Miliar-García; Adriana Huertas-Vazquez; Marta Menjivar; Sandra Romero-Hidalgo; Niels H Wacher; M Teresa Tusie-Luna; Miguel Cruz; Carlos A Aguilar-Salinas; Samuel Canizales-Quinteros
Journal:  Diabetes       Date:  2007-11-14       Impact factor: 9.461

7.  Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity.

Authors:  Mayumi Ishikawa; Yuko Iwasaki; Shigeru Yatoh; Toyonori Kato; Shin Kumadaki; Noriyuki Inoue; Takashi Yamamoto; Takashi Matsuzaka; Yoshimi Nakagawa; Naoya Yahagi; Kazuto Kobayashi; Akimitsu Takahashi; Nobuhiro Yamada; Hitoshi Shimano
Journal:  J Lipid Res       Date:  2008-08-05       Impact factor: 5.922

8.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

9.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

10.  Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations.

Authors:  Masahiro Koseki; Akifumi Matsuyama; Kazuhiro Nakatani; Miwako Inagaki; Hajime Nakaoka; Ryota Kawase; Miyako Yuasa-Kawase; Kazumi Tsubakio-Yamamoto; Daisaku Masuda; Jose C Sandoval; Tohru Ohama; Yumiko Nakagawa-Toyama; Fumihiko Matsuura; Makoto Nishida; Masato Ishigami; Ken-ichi Hirano; Naoki Sakane; Yoshitaka Kumon; Tadashi Suehiro; Tadashi Nakamura; Iichiro Shimomura; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2009-06-25       Impact factor: 4.928

View more
  24 in total

1.  The nuclear orphan receptor Nur77 is a lipotoxicity sensor regulating glucose-induced insulin secretion in pancreatic β-cells.

Authors:  Olivier Briand; Audrey Helleboid-Chapman; Maheul Ploton; Nathalie Hennuyer; Rodolphe Carpentier; François Pattou; Brigitte Vandewalle; Ericka Moerman; Valery Gmyr; Julie Kerr-Conte; Jérôme Eeckhoute; Bart Staels; Philippe Lefebvre
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 2.  Prion-Like Protein Aggregates and Type 2 Diabetes.

Authors:  Abhisek Mukherjee; Claudio Soto
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

Review 3.  Type 2 diabetes as a protein misfolding disease.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Peter C Butler; Claudio Soto
Journal:  Trends Mol Med       Date:  2015-05-18       Impact factor: 11.951

4.  Outcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients.

Authors:  Marcelo Santos Sampaio; Hung-Tien Kuo; Suphamai Bunnapradist
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

Review 5.  HDL dysfunction in diabetes: causes and possible treatments.

Authors:  Dan Farbstein; Andrew P Levy
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-03

6.  Age is positively associated with high-density lipoprotein cholesterol among African Americans in cross-sectional analysis: the Jackson Heart Study.

Authors:  Jane L Harman; Michael E Griswold; Neal O Jeffries; Anne E Sumner; Daniel F Sarpong; Ermeg L Akylbekova; Evelyn R Walker; Sharon B Wyatt; Herman A Taylor
Journal:  J Clin Lipidol       Date:  2011-03-02       Impact factor: 4.766

7.  Comparing Multiple Linear Regression and Machine Learning in Predicting Diabetic Urine Albumin-Creatinine Ratio in a 4-Year Follow-Up Study.

Authors:  Li-Ying Huang; Fang-Yu Chen; Mao-Jhen Jhou; Chun-Heng Kuo; Chung-Ze Wu; Chieh-Hua Lu; Yen-Lin Chen; Dee Pei; Yu-Fang Cheng; Chi-Jie Lu
Journal:  J Clin Med       Date:  2022-06-24       Impact factor: 4.964

Review 8.  Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Authors:  Ping Cao; Peter Marek; Harris Noor; Vadim Patsalo; Ling-Hsien Tu; Hui Wang; Andisheh Abedini; Daniel P Raleigh
Journal:  FEBS Lett       Date:  2013-02-01       Impact factor: 4.124

Review 9.  Mechanisms of islet amyloidosis toxicity in type 2 diabetes.

Authors:  Andisheh Abedini; Ann Marie Schmidt
Journal:  FEBS Lett       Date:  2013-01-18       Impact factor: 4.124

10.  Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study.

Authors:  Jamie Morton; Sophia Zoungas; Qiang Li; Anushka A Patel; John Chalmers; Mark Woodward; David S Celermajer; Joline W J Beulens; Ronald P Stolk; Paul Glasziou; Martin K C Ng
Journal:  Diabetes Care       Date:  2012-08-13       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.